During 2018, Garden Ltd commenced a research and development project on a promising new product. Garden Ltd prepares its financial statements annually on 30 June. The carrying amount of the deferred development costs for this project at 1 July 2019 was $80,000. From 1 July 2019 to 31 December 2019, Garden Ltd incurred $40,000 of research expenditures and capitalised an additional $100,000 of development expenditures (all paid in cash). The project was completed on 31 December 2019 and production started on 1 January 2020. Profitable sales were expected for a total of three years commencing on 1 January 2020. The recoverable amount of the deferred development costs on 30 June 2020 and 30 June 2021 is as follows: 30 June 2020 30 June 2021 Recoverable $300,000 $55,000 amount a) Prepare the required journal entries for Garden Ltd for the financial year ending 30 June 2020. Note: workings are not required to be shown. (4 marks) --- -- b) Prepare the required journal entries for Garden Ltd for the financial year ending 30 June 2021. Note: workings are not required to be shown. (4 marks) c) During 2022, the CFO of Garden Ltd expresses an interest in using the Revaluation Model to measure its deferred development costs. Under AASB 138, would Garden Ltd be permitted to adopt this accounting policy for this particular asset? Explain why (or why not)